News
Thailand became the first country in Asia to remove marijuana from its list of illegal narcotics. Cannabis was decriminalised ...
16d
Stockhead on MSNHealth Check: Tetratherix breaks biotech IPO drought with 13pc gain on debutToday’s ASX debut of wound management house Tetratherix (ASX:TTX) has raised the hopes of other life-science plays that have ...
David is then joined by George Conway for a conversation about the dangers our legal institutions are facing in the Trump presidency. They discuss Conway’s journey from corporate litigator to ...
The Ultimate List of the Top 100 TV Shows and Web Series of All Time 🎥 Television has evolved into a powerful storytelling ...
Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...
Singapore-made gel allows lab testing of drugs on live samples from advanced abdominal cancer Find out what’s new on ST website and app.
Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best young stocks to buy and hold for 5 years.
The Flair trial saw two targeted cancer drugs perform better than standard chemotherapy, halting disease progression in 94% of patients.
Drug developer NextCure said on Monday it had signed a deal worth up to $745 million with China-based drugmaker Simcere Zaiming to develop a cancer therapy for solid tumors.
The colours green and white are the signature colours of the Anti-Drug Ribbon. Read more at straitstimes.com. Read more at straitstimes.com.
9d
Malay Mail on MSNCould the secret to beating cancer be hiding in soya sauce? Singapore scientists are taking a closer lookThe Straits Times reported today that Kitkoji, a spin-off from heritage brand Nanyang Sauce, is working with the National ...
AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in myelodysplastic syndrome. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results